Ponte Vedra pharmaceutical company debuts on Nasdaq - Jacksonville Business Journal

A biopharmaceutical startup led by the former CEO of one Jacksonville's fastest-growing companies debuted on the Nasdaq stock exchange on Friday, priced at $5 a share.

The drug being developed by Cadrenal is an oral anti-coagulant that Pham has previously said could replace warfarin as a standard medication. The company is looking to sell 1.4 million shares of stock, raising $7 million before expenses. Various existing shareholders, including the Boys & Girls Club of Northeast Florida, are expected to sell another 1.7 million shares.

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Jacksonville hospitals ranked among best in U.S. by Healthgrades - Jacksonville Business JournalMayo Clinic and a pair of HCA facilities made the exclusive list. How much did these hospitals pay Healthgrades for their rankings?
Fonte: JaxBizJournal - 🏆 599. / 51 Consulte Mais informação »

Mark Cuban on disrupting the pharmaceutical industry - CEO SpotlightMark Cuban, CEO of Cuban Companies, joins David Johnson on this episode of CEO Spotlight.
Fonte: KRLD - 🏆 75. / 68 Consulte Mais informação »

Study: Florida among states with most new home builds - Jacksonville Business JournalUtah is the state with the most new construction homes being developed, with 11.7 new builds per 1,000 residents.
Fonte: JaxBizJournal - 🏆 599. / 51 Consulte Mais informação »